WASHINGTON, Oct 10 (Reuters) - New Jersey-based

drugmaker Teva has agreed to pay $450 million to resolve

allegations that it violated an anti-kickback statute and the

False Claims Act, the U.S. Justice department said in a

statement on Thursday.

"Kickbacks designed to induce referrals or purchases of

healthcare goods or services distort physician and patient

decision-making, thwart competition and bypass controls put in

place to protect federal health care programs," said Principal

Deputy Assistant Attorney General Brian M. Boynton, head of the

department's civil division.